Immunome, Inc.
IMNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$43 | -$42 | -$80 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5 | $6 | $5 |
| Change in WC | $10 | -$12 | -$17 | $5 |
| Other Non-Cash | $6 | -$0 | -$1 | $27 |
| Operating Cash Flow | -$41 | -$49 | -$53 | -$42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$4 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$123 | $0 | -$74 |
| Inv. Sales/Matur. | $125 | $60 | $15 | $85 |
| Other Inv. Act. | $0 | $0 | -$6 | -$0 |
| Investing Cash Flow | $124 | -$64 | $5 | $10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $45 | -$0 | $162 | $20 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $45 | -$0 | $162 | $20 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $129 | -$114 | $114 | -$12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $144 | $258 | $143 | $156 |
| End Cash | $273 | $144 | $258 | $143 |
| Free Cash Flow | -$42 | -$50 | -$57 | -$43 |